» Articles » PMID: 36459898

CT Radiomics for Differentiating Oncocytoma from Renal Cell Carcinomas: Systematic Review and Meta-analysis

Overview
Journal Clin Imaging
Publisher Elsevier
Specialty Radiology
Date 2022 Dec 2
PMID 36459898
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Radiomics is a type of quantitative analysis that provides a more objective approach to detecting tumor subtypes using medical imaging. The goal of this paper is to conduct a comprehensive assessment of the literature on computed tomography (CT) radiomics for distinguishing renal cell carcinomas (RCCs) from oncocytoma.

Methods: From February 15th 2012 to 2022, we conducted a broad search of the current literature using the PubMed/MEDLINE, Google scholar, Cochrane Library, Embase, and Web of Science. A meta-analysis of radiomics studies concentrating on discriminating between oncocytoma and RCCs was performed, and the risk of bias was assessed using the Quality Assessment of Diagnostic Accuracy Studies method. The pooled sensitivity, specificity, and diagnostic odds ratio were evaluated via a random-effects model, which was applied for the meta-analysis. This study is registered with PROSPERO (CRD42022311575).

Results: After screening the search results, we identified 6 studies that utilized radiomics to distinguish oncocytoma from other renal tumors; there were a total of 1064 lesions in 1049 patients (288 oncocytoma lesions vs 776 RCCs lesions). The meta-analysis found substantial heterogeneity among the included studies, with pooled sensitivity and specificity of 0.818 [0.619-0.926] and 0.808 [0.537-0.938], for detecting different subtypes of RCCs (clear cell RCC, chromophobe RCC, and papillary RCC) from oncocytoma. Also, a pooled sensitivity and specificity of 0.83 [0.498-0.960] and 0.92 [0.825-0.965], respectively, was found in detecting oncocytoma from chromophobe RCC specifically.

Conclusions: According to this study, CT radiomics has a high degree of accuracy in distinguishing RCCs from RO, including chromophobe RCCs from RO. Radiomics algorithms have the potential to improve diagnosis in scenarios that have traditionally been ambiguous. However, in order for this modality to be implemented in the clinical setting, standardization of image acquisition and segmentation protocols as well as inter-institutional sharing of software is warranted.

Citing Articles

Radiomics and machine learning for renal tumor subtype assessment using multiphase computed tomography in a multicenter setting.

Uhlig A, Uhlig J, Leha A, Biggemann L, Bachanek S, Stockle M Eur Radiol. 2024; 34(10):6254-6263.

PMID: 38634876 PMC: 11399155. DOI: 10.1007/s00330-024-10731-6.


Magnetic resonance imaging based on radiomics for differentiating T1-category nasopharyngeal carcinoma from nasopharyngeal lymphoid hyperplasia: a multicenter study.

Cheng J, Su W, Wang Y, Zhan Y, Wang Y, Yan S Jpn J Radiol. 2024; 42(7):709-719.

PMID: 38409300 DOI: 10.1007/s11604-024-01544-0.


CT-derived radiomics predict the growth rate of renal tumours in von Hippel-Lindau syndrome.

Singh S, Dehghani Firouzabadi F, Chaurasia A, Homayounieh F, Ball M, Huda F Clin Radiol. 2024; 79(5):e675-e681.

PMID: 38383255 PMC: 11075775. DOI: 10.1016/j.crad.2024.01.029.


Exploratory Analysis of the Role of Radiomic Features in the Differentiation of Oncocytoma and Chromophobe RCC in the Nephrographic CT Phase.

Aymerich M, Garcia-Baizan A, Franco P, Otero-Garcia M Life (Basel). 2023; 13(10).

PMID: 37895332 PMC: 10607929. DOI: 10.3390/life13101950.


A pilot radiometabolomics integration study for the characterization of renal oncocytic neoplasia.

Klontzas M, Koltsakis E, Kalarakis G, Trpkov K, Papathomas T, Sun N Sci Rep. 2023; 13(1):12594.

PMID: 37537362 PMC: 10400617. DOI: 10.1038/s41598-023-39809-9.


References
1.
Kim J, Li S, Khandwala Y, Chung K, Park H, Chung B . Association of Prevalence of Benign Pathologic Findings After Partial Nephrectomy With Preoperative Imaging Patterns in the United States From 2007 to 2014. JAMA Surg. 2018; 154(3):225-231. PMC: 6439638. DOI: 10.1001/jamasurg.2018.4602. View

2.
Galia M, Albano D, Bruno A, Agrusa A, Romano G, Di Buono G . Imaging features of solid renal masses. Br J Radiol. 2017; 90(1077):20170077. PMC: 5858810. DOI: 10.1259/bjr.20170077. View

3.
Yang G, Gong A, Nie P, Yan L, Miao W, Zhao Y . Contrast-Enhanced CT Texture Analysis for Distinguishing Fat-Poor Renal Angiomyolipoma From Chromophobe Renal Cell Carcinoma. Mol Imaging. 2019; 18:1536012119883161. PMC: 6801892. DOI: 10.1177/1536012119883161. View

4.
Woo S, Cho J, Kim S, Kim S . Comparison of segmental enhancement inversion on biphasic MDCT between small renal oncocytomas and chromophobe renal cell carcinomas. AJR Am J Roentgenol. 2013; 201(3):598-604. DOI: 10.2214/AJR.12.10372. View

5.
Miles K, Ganeshan B, Hayball M . CT texture analysis using the filtration-histogram method: what do the measurements mean?. Cancer Imaging. 2013; 13(3):400-6. PMC: 3781643. DOI: 10.1102/1470-7330.2013.9045. View